269 tracked 13F filers disclose a position in LQDA as of the latest SEC 13F filings, a combined $3.0B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FARALLON CAPITAL MANAGEMENT, L.L.C. | $326.7M | 8.7M | —Held | Q1 2026 | |
| 2 | Caligan Partners LP | $306.4M | 8.1M | —Held | Q1 2026 | |
| 3 | BlackRock, Inc. | $207.2M | 5.5M | ▲~0% Added · +781 sh | Q1 2026 | |
| 4 | FINDELL CAPITAL MANAGEMENT LLC | $279.2M | 3.5M | —Held | Q2 2026 | |
| 5 | STATE STREET CORP | $241.6M | 3.0M | ▲+61% Added · +1.1M sh | Q2 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $110.5M | 2.9M | →First observed position No prior filed position | Q1 2026 | |
| 7 | Opaleye Management Inc. | $88.8M | 2.5M | ▲+4.5% Added · +110K sh | Q1 2026 | |
| 8 | BANK OF AMERICA CORP /DE/ | $86.3M | 2.3M | ▲+19% Added · +360K sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $169.2M | 2.1M | ▲+10.0% Added · +192K sh | Q2 2026 | |
| 10 | Caprock Group, LLC | $112.4M | 1.4M | ▲+3.1% Added · +43K sh | Q2 2026 | |
| 11 | MPM BioImpact LLC | $53.0M | 1.4M | ▲+0.3% Added · +4K sh | Q1 2026 | |
| 12 | FULLER & THALER ASSET MANAGEMENT, INC. | $96.4M | 1.2M | ▲New +1.2M sh | Q2 2026 | |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $37.8M | 1.0M | ▲+282% Added · +739K sh | Q1 2026 | |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | $36.0M | 953K | ▲26× Added · +916K sh | Q1 2026 | |
| 15 | D. E. Shaw & Co., Inc. | $32.9M | 873K | ▼−48% Reduced · −794K sh | Q1 2026 | |
| 16 | GOLDMAN SACHS GROUP INC | $30.6M | 812K | ▲+15% Added · +108K sh | Q1 2026 | |
| 17 | JANE STREET GROUP, LLC | $30.0M | 796K | ▲+91% Added · +378K sh | Q1 2026 | |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | $23.9M | 633K | →First observed position No prior filed position | Q1 2026 | |
| 19 | BOOTHBAY FUND MANAGEMENT, LLC | $23.6M | 625K | ▲+1.9% Added · +12K sh | Q1 2026 | |
| 20 | FMR LLC | $22.0M | 582K | ▲+54% Added · +204K sh | Q1 2026 | |
| 21 | NORTHERN TRUST CORP | $21.9M | 580K | ▲+3.4% Added · +19K sh | Q1 2026 | |
| 22 | TWO SIGMA INVESTMENTS, LP | $21.3M | 563K | ▲+61% Added · +213K sh | Q1 2026 | |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21.0M | 557K | ▼−0.8% Reduced · −5K sh | Q1 2026 | |
| 24 | VANGUARD FIDUCIARY TRUST CO | $17.8M | 472K | →First observed position No prior filed position | Q1 2026 | |
| 25 | FEDERATED HERMES, INC. | $16.6M | 439K | ▼−9.8% Reduced · −48K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 6 funds opened a new position in LQDA and 26 added to an existing one, while 23 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 147 funds | $170.6B |
| AMAZON.COM INCAMZN | 143 funds | $122.3B |
| NVIDIA CORPNVDA | 142 funds | $258.3B |
| MICRON TECHNOLOGY INCMU | 142 funds | $29.0B |
| APPLE INCAAPL | 139 funds | $193.3B |
| ALPHABET INC-CL AGOOGL | 139 funds | $95.4B |
| ALPHABET INC-CL CGOOG | 137 funds | $85.0B |
| BROADCOM INCAVGO | 136 funds | $102.8B |
| META PLATFORMS INC-CLASS AMETA | 136 funds | $71.7B |
| ELI LILLY & COLLY | 135 funds | $53.1B |
| JPMORGAN CHASE & COJPM | 132 funds | $37.1B |
| LAM RESEARCH CORPLRCX | 132 funds | $21.4B |
Ranked by how many of LQDA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Adair Jason | Chief Business Officer | Sell (S) | 42K | $2.9M |
| Aug 21, 2026 | Adair Jason | Chief Business Officer | Sell (S) | 32K | $2.2M |
| Aug 20, 2026 | Rielly-Gauvin Katherine | Director | Sell (S) | 18K | $1.3M |
| Aug 19, 2026 | Saggar Rajeev | Chief Medical Officer | Sell (S) | 50K | $3.7M |
| Aug 19, 2026 | Rielly-Gauvin Katherine | Director | Sell (S) | 37K | $2.8M |
| Aug 17, 2026 | Saggar Rajeev | Chief Medical Officer | Sell (S) | 30K | $2.3M |
| Jul 27, 2026 | Adair Jason | Chief Business Officer | Sell (S) | 688 | $60K |
| Jul 27, 2026 | Boyle Dana | Chief Accounting Officer | Sell (S) | 2K | $140K |
| Jul 23, 2026 | Bloch Stephen M | Director | Sell (S) | 96K | $8.6M |
| Jul 23, 2026 | Bloch Stephen M | Director | Sell (S) | 4K | $327K |
| Jul 22, 2026 | Bloch Stephen M | Director | Sell (S) | 37K | $3.3M |
| Jul 22, 2026 | Bloch Stephen M | Director | Sell (S) | 48K | $4.3M |
Connected entities for LQDA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/LQDA/capital-change-brief"
Use Arkolith's capital_change_brief for LQDA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for LQDA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.